GH

Gosseya Hussain

Active Director Director DIN 10741489
DIN 10741489 First appointment Aug 2024 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Gosseya Hussain

Data last updated:

Gosseya Hussain is a Director at Invipro Pharmaceuticals Private Limited (since 2024). The company operates in Chemicals. Invipro Pharmaceuticals Private Limited reported revenue of ₹25.4 Lakh (FY 2024).

DIN 10741489
Primary Designation Director
Industry Chemicals
First Appointment 13 Aug 2024
Oldest Company Age 4 yrs
Largest company Invipro Pharmaceuticals Private Limited · ₹25.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Aug 20242022₹25.4 Lakh (FY 2024)Active

Board colleagues of Gosseya Hussain

Directorship timeline

Open interactive timeline →
Invipro Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gosseya Hussain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gosseya Hussain

Gosseya Hussain currently holds 1 directorship: Invipro Pharmaceuticals Private Limited (Director, since 13 Aug 2024, revenue ₹25.4 Lakh (FY 2024)).

Gosseya Hussain was first appointed on 13 Aug 2024 as Director at Invipro Pharmaceuticals Private Limited.

The current boards of Gosseya Hussain's companies include Sandeep Kishore (Invipro Pharmaceuticals Private Limited), Uma Shankar Sahni (Invipro Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available